Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Malignant Lymphoma

Free Subscription 05.11.2018 1 Blood 2 Haematologica 2 N Engl J Med 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Blood

1. DREYLING M, Klapper W, Rule S
   Blastoid and pleomorphic mantle cell lymphoma: still a diagnostic and therapeutic challenge!
   Blood. 2018 Nov 1. pii: blood-2017-08-737502. doi: 10.1182/blood-2017-08-737502.
   PubMed     Text format     Abstract available
   
   

   
   Haematologica

2. HAGENBEEK A, Mooij H, Zijlstra J, Lugtenburg P, et al
   Phase 1 dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: the Transplant BRaVE study.
   Haematologica. 2018 Oct 31. pii: haematol.2018.196899.
   PubMed     Text format    
   
   
3. BURKHARD R, Keller I, Arambasic M, Juskevicius D, et al
   TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation via NF-kappaB mediated signaling in B-cells.
   Haematologica. 2018 Oct 31. pii: haematol.2018.201590.
   PubMed     Text format     Abstract available
   
   

   
   N Engl J Med

4. ADVANI R, Flinn I, Popplewell L, Forero A, et al
   CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma.
   N Engl J Med. 2018;379:1711-1721.
   PubMed     Text format     Abstract available
   
   
5. BACH PB
   National Coverage Analysis of CAR-T Therapies - Policy, Evidence, and Payment.
   N Engl J Med. 2018;379:1396-1398.
   PubMed     Text format    
   
   

   
   Proc Natl Acad Sci U S A

6. HUANG Q, Chen L, Yang L, Xie X, et al
   MDMX acidic domain inhibits p53 DNA binding in vivo and regulates tumorigenesis.
   Proc Natl Acad Sci U S A. 2018;115:E3368-E3377.
   PubMed     Text format     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: